Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Tocris Bioscience™ Purvalanol B
GREENER_CHOICE

Catalog No. 158110
Change view
Click to view available options
Quantity:
10 mg
50 mg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
15-811-0 10 mg
15-815-0 50 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
This item is not returnable. View return policy
Catalog No. 15-811-0 Supplier Tocris Bioscience™ Supplier No. 1581/10
Only null left
Add to Cart
Add to Cart
This item is not returnable. View return policy

Selective cdk inhibitor; potently inhibits cdk1, cdk2 and cdk5

Purvalanol B is a cyclin-dependent kinase (cdk) inhibitor (reported IC50 values are 6 nM for cdk1 and cdk5, and 6 - 9 nM for cdk2, depending on binding partner). Purvalanol B is selective over a range of other protein kinases (IC50 >10,000 nM). Purvalanol B shows antiproliferative properties, mediated by ERK1 and ERK2. Purvalanol B induces autophagy in cellular models and induces apoptosis in cancer cells, the apoptotic effects can be increased by combining with Rapamycin (Cat. No. 1292).

Chemical Identifiers

CAS 212844-54-7
Molecular Formula C20H25ClN6O3

Specifications

Quantity 10 mg
Formula Weight 432.91
Purity >99%
Molecular Weight (g/mol) 432.909
Chemical Name or Material Purvalanol B
Recommended Storage Store at +4°C
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.